Incretins, diabetes, and bariatric surgery: a review

Surg Obes Relat Dis. 2005 Nov-Dec;1(6):589-97; discussion 597-8. doi: 10.1016/j.soard.2005.09.001. Epub 2005 Oct 27.

Authors

Rachel Fetner¹, James McGinty, Colleen Russell, F Xavier Pi-Sunyer, Blandine Laferrère

Affiliation

¹ Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, St. Luke's-Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, New York, USA. rachelfetner@yahoo.com

PMID: 16925299
DOI: 10.1016/j.soard.2005.09.001

No abstract available

Publication types

Review

MeSH terms

Bariatric Surgery
Biliopancreatic Diversion
Cerebral Cortex / metabolism*
Comorbidity
Diabetes Mellitus, Type 2 / epidemiology
Diabetes Mellitus, Type 2 / physiopathology*
Diabetes Mellitus, Type 2 / surgery
Gastric Inhibitory Polypeptide / metabolism*
Gastric Inhibitory Polypeptide / physiology
Gastroplasty
Glucagon-Like Peptide 1 / metabolism*
Glucagon-Like Peptide 1 / physiology
Humans
Obesity, Morbid / epidemiology
Obesity, Morbid / physiopathology*
Obesity, Morbid / surgery
Postoperative Period
Satiety Response

Substances

Gastric Inhibitory Polypeptide
Glucagon-Like Peptide 1